Dacoplice 30 mg Tablet
$691.30
$539.21
Dacoplice 30 mg Tablet is a targeted therapy specifically designed for adults suffering from advanced or metastatic non-squamous non-small cell lung cancer. This medication serves as a primary treatment option or can be utilized after conventional chemotherapy has proven ineffective. Dacoplice works by inhibiting the activity of the epidermal growth factor receptor (EGFR), particularly in tumors harboring specific mutations, such as the exon 19 deletion or the L858R substitution mutation. It is crucial for patients to undergo genetic testing to confirm these mutations before starting treatment, as Dacoplice is not suitable for everyone. Additionally, this medication is not recommended for use in children or adolescents due to a lack of safety data in these populations. Patients should discuss potential side effects and interactions with their healthcare provider to ensure a comprehensive understanding of their treatment plan. By utilizing Dacoplice, eligible patients may experience improved outcomes in their fight against lung cancer. Always consult a healthcare professional for personalized advice regarding cancer treatment options.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Dacoplice 30 mg tablet is primarily indicated for the treatment of non-small cell lung cancer (NSCLC). This type of lung cancer is characterized by the growth of abnormal cells in the lung tissue. By targeting specific pathways involved in cancer cell proliferation, Dacoplice 30 mg tablet helps to manage the disease effectively. Patients may benefit from its use as part of a comprehensive treatment plan.
• In cases where NSCLC has progressed or recurred, Dacoplice 30 mg tablet may be utilized to help control the disease. It works by interfering with the cancer cell's ability to grow and divide, potentially leading to improved outcomes for patients. Many oncologists consider Dacoplice 30 mg tablet a valuable option when other treatments have been exhausted. This can provide hope for individuals facing advanced stages of lung cancer.
• Dacoplice 30 mg tablet is often prescribed for patients with specific genetic mutations associated with non-small cell lung cancer. By personalizing treatment based on these mutations, Dacoplice 30 mg tablet aims to enhance the efficacy of cancer therapy. This tailored approach helps in achieving better management of the disease. Consequently, patients may experience a more targeted treatment regimen that aligns with their unique cancer profile.
• The use of Dacoplice 30 mg tablet may also be considered in combination with other therapies for enhanced effectiveness. Oncologists may recommend this medication as part of a multi-faceted approach to treating non-small cell lung cancer. By integrating Dacoplice 30 mg tablet into a broader treatment strategy, the overall impact on the disease can be optimized. This collaborative treatment model is designed to improve patient outcomes in managing lung cancer.
Benefits
Dacoplice 30 mg Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Dacoplice 30 mg can help to slow the progression of cancer. Dacoplice 30 mg Tablet may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Dacoplice 30 mg Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
Like all medications, Dacoplice 30 mg Tablet can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Itching
• Breathlessness
• Mouth sores
• Rashes
• Pain
• Cold
• Hair loss
• Dry red itchy eyes
• loss of weight
Common Side Effects
• Kidney disease
• Liver disease
• Respiratory distress
• Asthma, ILD ( interstitial lung disease)
• Skin conditions
• sensitivity, skin fissures, hypertrichosis, skin exfoliation, Keratitis, dehydration
• Stomatitis
• Nausea
• Constipation
• loss of appetite
• cough
• Pain in extremities
• Insomnia
• Alopecia
• Asthenia
How To Use
Dacoplice 30 mg Tablet should be taken on an empty stomach at least one hour before or two hours after a meal. Always take Dacoplice 30 mg Tablet exactly as directed by your doctor, including the recommended number and timing of tablets. Do not change your dose or stop this medicine without consulting your doctor. If you miss a dose, take it as soon as possible. If the next dose is scheduled within 12 hours, skip the missed dose and continue with the regular dosing regimen. It is not recommended to take two doses at the same time. If you overdose on Dacoplice 30 mg, contact your doctor immediately or seek medical help at the nearest hospital emergency department.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Dacoplice 30 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Dacoplice 30 mg Tablet is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Dacoplice 30 mg Tablet is recommended. The use of Dacoplice 30 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Dacoplice 30 mg Tablet. Dacoplice 30 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Dacoplice 30 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Dacoplice 30 mg Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Dacoplice 30 mg Tablet is recommended. The use of Dacoplice 30 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Dacoplice 30 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Dacoplice 30 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Dacoplice 30 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Dacoplice 30 mg.